Cannula-based drug delivery to the guinea pig round window causes a lasting hearing loss that may be temporarily mitigated by BDNF
- 1 December 2017
- journal article
- Published by Elsevier in Hearing Research
- Vol. 356, 104-115
Abstract
No abstract availableKeywords
Funding Information
- Garnett Passe and Rodney Williams Memorial Foundation
This publication has 42 references indexed in Scilit:
- Brain-Derived Neurotrophic Factor Modulates Auditory Function in the Hearing CochleaJournal of the Association for Research in Otolaryngology, 2011
- Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatmentHearing Research, 2011
- Dynamic changes in hair cell stereocilia and cochlear transduction after noise exposureBiochemical and Biophysical Research Communications, 2011
- OTO-104Otology & Neurotology, 2011
- Distribution of Dexamethasone and Preservation of Inner Ear Function following Intratympanic Delivery of a Gel-Based FormulationAudiology and Neurotology, 2010
- Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea PigsJournal of the Association for Research in Otolaryngology, 2009
- Noise Exposure of the Inner Ear During Drilling a Cochleostomy for Cochlear ImplantationThe Laryngoscope, 2007
- Two-phase Endolymphatic Hydrops: A New Dynamic Guinea Pig ModelActa Oto-Laryngologica, 1997
- NGF, BDNF and NT-3 play unique roles in the in vitro development and patterning of innervation of the mammalian inner earDevelopmental Brain Research, 1996
- Potassium-Induced Release of Endogenous Amino Acids in the Guinea Pig CochleaJournal of Neurochemistry, 1985